Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018
|
|
- Lora Bennett
- 5 years ago
- Views:
Transcription
1 Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report May 2018 Prepared by the Canadian Cardiovascular Society (CCS)/Canadian Society of Cardiac Surgeons (CSCS) Cardiac Surgery Quality Working Group
2 Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report, May 2018 Background In 2013 the Cardiac Surgery Working Group of the Canadian Cardiovascular Society (CCS) Quality Project defined quality indicators in cardiac surgery for pan-canadian reporting. Mortality indicators were defined as 30-day mortality after the three most common cardiac surgical procedures, coronary artery bypass (CABG), aortic valve replacement (AVR), and combined AVR and CABG, as well as 30-day readmission after CABG. Although CIHI had been reporting pan-canadian cardiac outcomes, substantial consultation and partnership with CIHI occurred, with extensive cohort and methodologic refinement. In 2016 a formal memorandum of understanding between CCS and CIHI was agreed to, with the purpose of facilitating and reporting of quality indicators publicly. The Cardiac Care Quality Indicators (CCQI) public report and CCS commentary were released in October 2017 based on a three year cohort of pooled data for fiscal years to The updated indicator results are based on 3 years of most recent pooled data to the end of fiscal year The purpose of public release of this data is for assessment of quality of cardiac care, for education and enlightenment, to promote transparency in the system of care, and to foster and stimulate quality improvement. Although many provinces and hospitals have high quality clinical databases, very few have systematic regular reviews for the purposes of quality, and until this process, national outcome reporting permitting comparisons have not been possible. Questions regarding administrative data methods and quality have arisen which will lead to improved chart documentation, data consistency and quality. Ironically, with rare exception, the high quality data in clinical
3 cardiac surgical databases is not available for hospital chart abstraction. This is an attainable objective. Data exchange across provincial health care jurisdictions is also challenging, and although CIHI is able to access national in-hospital mortality, facilitated access to vital statistics data for longer term mortality is essential, and should be expedited. The indicators reported reflect the highest volume cardiac surgical procedures, which should be associated with consistent excellent results, and which lend themselves to reproducible systems and processes of care. The first public report has increased the awareness of the outcomes reported in the cardiac community and has increased engagement of institutions and provinces. The risk factor analyses provide important information for clinicians and patients in estimating individual procedural risk. Methodology and Cohort Selection Model specifications (coefficients, odds ratios and p-values) for the indicators were developed using the logistic regression model based on three years of pooled data ( to ). This can be regarded as the model-derivation cohort. The reported (test) cohort includes the most recent three fiscal year data to : , , In-hospital mortality is reported and for hospital stays less than 30 days will underestimate true 30-day mortality. The table of contents contained in these updated indicator results provide important links to this May 2018 public release and to detailed technologic methodology.
4 Select Sample from Table 1 Cardiac Care quality indicator crude and risk-adjusted results, by reporting level (Canada, province, cardiac care centre), to (3 years of pooled data) Reporting level Organization Indicator name Crude rate Predicted rate Riskadjusted rate 95% confidence interval riskadjusted rate: LCL 95% confidence interval riskadjusted rate: UCL Statistically significant Canada Province Canada 1.4 n/a n/a n/a n/a n/a Newfoundland and Labrador 2.7 n/a Yes Province Nova Scotia 2.1 n/a Yes Province New Brunswick 1.3 n/a No Province Quebec 1.7 n/a No Province Ontario 1.4 n/a No Province Manitoba 0.9 n/a Yes Province Saskatchewan 30-Day In- 0.9 n/a No Hospital Province Province Alberta British Columbia Mortality After Isolated CABG n/a n/a No Yes PCI: Percutaneous coronary intervention. AVR: Aortic valve replacement. n/a: Not applicable. Mortality indicators are based on in-hospital mortality only. Isolated means that no other cardiac surgeries, valve procedures or core concomitant procedures were performed during the episode of care. There is no comprehensive capture of PCI data in Quebec, so Quebec could not be included in analyses for 30-day in-hospital mortality after PCI, 30-day readmission after PCI and PCI volume by centre. Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, Hospital Morbidity Database and National Ambulatory Care Reporting System, , and , Canadian Institute for Health Information. This table provides the numeric crude and risk-adjusted outcomes for all reported data by province and hospital for the first 11 months of each fiscal year, and the sum total of the fiscal years, totaling 33 months of data to the end of February The 11 month fiscal cohorts allowed 30-day hospital readmission rates to fiscal year end to be reported for patients discharged within the first 11 months of the fiscal year. The Table contains the numeric values for the data displayed in Figures 1-8. The arrows at the top of each column allow filtering of the displayed data by province, hospital, indicator, and year and permit ordering of the rows as well.
5 Canadian average rate (per 100) Coronary Artery Bypass (CABG) The 33 month cohort having this isolated procedure comprised 43,782 patients from 32 cardiac surgical centres nationally. Figure 1 Canadian average mortality rates by indicator and fiscal year, to Day In-Hospital Mortality After PCI 30-Day In-Hospital Mortality After 30-Day In-Hospital Mortality After Isolated CABG Isolated AVR Mortality indicators 30-Day In-Hospital Mortality After CABG and AVR * Mortality indicators are based on in-hospital mortality only. Isolated means that no other cardiac surgeries, valve procedures or core concomitant procedures were performed during the hospitalization episode of care. PCI: Percutaneous coronary intervention. AVR: Aortic valve replacement. Discharge Abstract Database, National Ambulatory Care Reporting System and Hospital Morbidity Database, , and , Canadian Institute for Health Information. Average annual in-hospital mortality after isolated CABG is low at 1.4% and has been constant year to year.
6 Figure 4 Cardiac care centre risk-adjusted results for 30-Day In-Hospital Mortality After Isolated CABG, to (3 years of pooled date) Canadian average mortality rates by indicator and fiscal year, to * Risk-adjusted rate is statistically significantly different from the Canadian average. 3 years of pooled data: to Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, National Ambulatory Care Reporting System and Hospital Morbidity Database, , and , Canadian Institute for Health Information. Figure 4 shows average in-hospital risk-adjusted mortality over the 33 month time frame with 95% confidence limits. Risk-adjusted mortality ranged from 0.4% to 3.5%. Hospital mortality rates with 95% confidence limits not overlapping the national mean of 1.4% or each other are significantly different from the comparator. The ability of the model used for risk-adjustment to discriminate mortality was 0.81 (C-statistic 0.81). Risk factors used in the model and the percentage of the cohort with each factor appear in Table 4:
7 Table 4 Risk factors for 30-Day In-Hospital Mortality After CABG, to (3 years of pooled data) Risk factor Number Percentage Coefficient Odds ratio Significance Intercept n/a n/a -5.6 n/a < Age (vs ) 2, Age (vs ) 13, < Age 80+ (vs ) 3, < Male (vs. female) 35, < Urgent/emergent admission 22, Shock < NSTEMI AMI/unspecified AMI (vs. stable 13, CAD) STEMI AMI (vs. stable CAD) 3, < Unstable angina (vs. stable CAD) 6, Previous AMI 3, Previous cardiac surgery Cardiac dysrhythmias (non-quebec 2, Cardiac dysrhythmias (Quebec 1, Multiple cardiac interventions in same 1, < episode of care (PCI, CABG) Peripheral vascular disease (non-quebec < Peripheral vascular disease (Quebec 1, < Acute renal failure (non-quebec Acute renal failure (Quebec Charlson group 1 (vs. 0) 17, < Charlson group 2 (vs. 0) 3, < PCI: Percutaneous coronary intervention. CAD: Coronary artery disease. AMI: Acute myocardial infarction. STEMI: ST elevation myocardial infarction. NSTEMI: Non ST elevation myocardial infarction. n/a: Not applicable. Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, Hospital Morbidity Database and National Ambulatory Care Reporting System, , and , Canadian Institute for Health Information.
8 Canadian average rate (per 100) Age greater than 70, female gender, urgent hospital admission, shock, acute myocardial infarction with or without ST-segment elevation, percutaneous coronary intervention within the same hospital episode of care, peripheral vascular disease, and a Charlson Comorbidity Index greater than 0 were all associated with increased mortality with the probability indicated by the odds ratio. The Charlson Comorbidity Index incorporates a number of preoperative comorbidities related to mortality such as congestive heart failure, dementia, chronic pulmonary disease, rheumatologic disease, liver disease, diabetes with organ failure, hemiplegia or paraplegia, renal disease, and HIV infection. Aortic Valve Replacement (AVR) The 33 month cohort of patients analyzed, was 7,523. Average national in-hospital mortality after isolated AVR over the three years was low at 1.2 to 1.3%. Figure 1 Canadian average mortality rates by indicator and fiscal year, to Day In-Hospital Mortality After PCI 30-Day In-Hospital Mortality After 30-Day In-Hospital Mortality After Isolated CABG Isolated AVR Mortality indicators Day In-Hospital Mortality After CABG and AVR * Mortality indicators are based on in-hospital mortality only. Isolated means that no other cardiac surgeries, valve procedures or core concomitant procedures were performed during the hospitalization episode of care. PCI: Percutaneous coronary intervention. AVR: Aortic valve replacement. Discharge Abstract Database, National Ambulatory Care Reporting System and Hospital Morbidity Database, , and , Canadian Institute for Health Information.
9 Overall 3-year risk-adjusted rate (per 100) Figure 5 Cardiac care centre risk-adjusted results for 30-Day In-Hospital Mortality After Isolated AVR, to (3 years of pooled data) Cardiac care centre Canadian average (1.3) * Risk-adjusted rate is statistically significantly different from the Canadian average. AVR: Aortic valve replacement. 3 years of pooled data: to Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, National Ambulatory Care Reporting System and Hospital Morbidity Database, , and , Canadian Institute for Health Information. Figure 5 shows average in-hospital risk-adjusted mortality over the 33 month time frame with 95% confidence limits. Risk-adjusted mortality ranged from 0 to 6.3%. Hospital mortality rates with 95% confidence limits not overlapping the national mean of 1.3% or each other are significantly different from the comparator. The ability of the model used for risk-adjustment to discriminate mortality was 0.82 (C-statistic 0.82). Risk factors used in the model and the percentage of the cohort with each factor appear in Table 5:
10 Table 5 Risk factors for 30-Day In-Hospital Mortality After Isolated AVR, to (3 years of pooled data) Risk factor Number Percentage Coefficient Odds ratio Significance Intercept n/a n/a -5.8 n/a < Age (vs ) Age (vs ) 2, Age 80+ (vs ) 1, < Male (vs. female) 4, Urgent/emergent admission 1, Shock Previous cardiac surgery Cerebrovascular disease (non-quebec Cerebrovascular disease (Quebec Cardiac dysrhythmias (non Quebec Cardiac dysrhythmias (Quebec Acute renal failure (non < Quebec Acute renal failure (Quebec Endocarditis Charlson group 1 (vs. 0) 1, < Charlson group 2 (vs. 0) < AVR: Aortic valve replacement. n/a: Not applicable. Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, Hospital Morbidity Database and National Ambulatory Care Reporting System, , and , Canadian Institute for Health Information. Age greater than 70, shock, previous cardiac surgery, acute renal failure (all jurisdictions except Quebec), cardiac dysrhythmias (Quebec only) and increased comorbidities as indicated by Charlson group were all predictive of increased mortality, with the odds ratios indicated in Table 5. Note that there are some risk factors with two coefficients one for the data submitted by Quebec and one for all other jurisdictions. Quebecspecific coefficients were included in the model to address differences in data collection.
11 Canadian average rate (per 100) Aortic Valve Replacement and Coronary Artery Bypass The 33 month cohort of patients analyzed was 5,934. Average national in-hospital mortality after combined AVR and CABG is higher than each procedure in isolation at 3.1%, and more variable, ranging from a high of 3.7% in to 2.6% in , and 3.1% in Figure 1 Canadian average mortality rates by indicator and fiscal year, to Day In-Hospital Mortality After PCI 30-Day In-Hospital Mortality After 30-Day In-Hospital Mortality After Isolated CABG Isolated AVR Mortality indicators 30-Day In-Hospital Mortality After CABG and AVR * Mortality indicators are based on in-hospital mortality only. Isolated means that no other cardiac surgeries, valve procedures or core concomitant procedures were performed during the hospitalization episode of care. PCI: Percutaneous coronary intervention. AVR: Aortic valve replacement. Discharge Abstract Database, National Ambulatory Care Reporting System and Hospital Morbidity Database, , and , Canadian Institute for Health Information.
12 Overall 3-year risk-adjusted rate (per 100) Figure 6 Cardiac care centre risk-adjusted results for 30-Day In-Hospital Mortality After CABG and AVR, to (3 years of pooled data) Cardiac care centre Canadian average (3.1) * Risk-adjusted rate is statistically significantly different from the Canadian average. AVR: Aortic valve replacement. 3 years of pooled data: to Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, National Ambulatory Care Reporting System and Hospital Morbidity Database, , and , Canadian Institute for Health Information. Figure 6 shows average in-hospital risk-adjusted mortality over the 33 month time frame with 95% confidence limits. Risk-adjusted mortality ranged from 0 to 6.6%. Hospital mortality rates with 95% confidence limits not overlapping the national mean of 3.1% or each other are significantly different from the comparator. The ability of the model used for risk-adjustment to discriminate mortality was 0.72 (C-statistic 0.72). Risk factors used in the model and the percentage of the cohort with each factor appear in Table 6:
13 Table 6 Risk factors for 30-Day In-Hospital Mortality After CABG and AVR, to (3 years of pooled data) Risk factor Number Percentage Coefficient Odds ratio Significance Intercept n/a n/a -3.9 n/a < Age (vs ) Age (vs ) 2, Age 80+ (vs ) 1, Male (vs. female) 4, Urgent/emergent admission 1, Shock < NSTEMI AMI Previous AMI Previous cardiac surgery Cardiac dysrhythmias (non Quebec Cardiac dysrhythmias (Quebec Multiple cardiac interventions in same episode of care (PCI, CABG) Acute renal failure (non Quebec Acute renal failure (Quebec Charlson group 1 (vs. 0) 2, Charlson group 2 (vs. 0) PCI: Percutaneous coronary intervention. AVR: Aortic valve replacement. AMI: Acute myocardial infarction. NSTEMI: Non ST elevation myocardial infarction. n/a: Not applicable. Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, Hospital Morbidity Database and National Ambulatory Care Reporting System, , and , Canadian Institute for Health Information.
14 Age above 70, female gender, urgent/emergent hospital admission, shock, acute myocardial infarction without ST-segment elevation, and previous acute myocardial infarction and PCI in the same episode of care, acute renal failure (all jurisdictions except Quebec), and higher composite comorbidity as indicated by Charlson group 2, increased the probability of in-hospital mortality with odds ratios as indicated in Table Day Readmission after Isolated Coronary Artery Bypass There were 3,932 readmissions within 30 days of discharge in 42,005 patients surviving to discharge. The incremental mortality from a variable discharge date to 30 days post discharge is not known, hence the true denominator of patients alive to be readmitted is smaller, and calculated readmission rates are underestimated. Average national 30- day readmission after isolated CABG over the three years was 9.4% and almost identical each year (Figure 1). Hospital readmission rates ranged from 6.2 to 12.8%.
15 Figure 8 Cardiac care centre risk-adjusted results for 30-Day All-Cause Readmission Rate After Isolated CABG, to (3 years of pooled data) * Risk-adjusted rate is statistically significantly different from the Canadian average. 3 years of pooled data: to Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, National Ambulatory Care Reporting System and Hospital Morbidity Database, , and , Canadian Institute for Health Information. Figure 8 shows average hospital 30-day readmission rates over the 33 month time frame with 95% confidence limits. Risk-adjusted readmission ranged from 6.8 to 12.8%. Hospital mortality 95% confidence limits not overlapping the national mean of 9.4% or each other are significantly different. Readmission rates with 95% confidence limits not overlapping the national mean of 1.4% or each other are significantly different from the comparator.
16 Risk factors predicting 30-day readmission were age greater than 70, female gender, urgent/emergent admission, acute myocardial infarction, cardiac dysrhythmias, PCI within the same episode of care, peripheral vascular disease, and increased Charlson Comorbidity Index. Table 8 Risk factors for 30-Day All-Cause Readmission Rate After Isolated CABG, to (3 years of pooled data) Risk factor Number Percentage Coefficient Odds ratio Significance Intercept n/a n/a -2.5 n/a < Age (vs ) 1, Age (vs ) 12, < Age 80+ (vs ) 2, < Male (vs. female) 34, < Urgent/emergent admission 21, Previous AMI 3, < Cardiac dysrhythmias (non-quebec 2, < Cardiac dysrhythmias (Quebec 1, Hypertension (non-quebec 5, Hypertension (Quebec 8, Multiple cardiac interventions in 1, same episode of care (PCI, CABG) Peripheral vascular disease (non < Quebec Peripheral vascular disease (Quebec 1, Acute renal failure (non-quebec Acute renal failure (Quebec Charlson group 1 (vs. 0) 16, < Charlson group 2 (vs. 0) 2, < PCI: Percutaneous coronary intervention. n/a: Not applicable. Model specifications (coefficients, odds ratios and p-values) were developed using the logistic regression model based on 3 years of pooled data ( to ). Discharge Abstract Database, Hospital Morbidity Database and National Ambulatory Care Reporting System, , and , Canadian Institute for Health Information.
Supplement materials:
Supplement materials: Table S1: ICD-9 codes used to define prevalent comorbid conditions and incident conditions Comorbid condition ICD-9 code Hypertension 401-405 Diabetes mellitus 250.x Myocardial infarction
More informationSupplementary Online Content
Supplementary Online Content Khera R, Dharmarajan K, Wang Y, et al. Association of the hospital readmissions reduction program with mortality during and after hospitalization for acute myocardial infarction,
More informationAppendix Identification of Study Cohorts
Appendix Identification of Study Cohorts Because the models were run with the 2010 SAS Packs from Centers for Medicare and Medicaid Services (CMS)/Yale, the eligibility criteria described in "2010 Measures
More informationWaiting Your Turn Wait Times for Health Care in Canada, 2017 Report
2017 Fraser Institute Waiting Your Turn Wait Times for Health Care in Canada, 2017 Report by Bacchus Barua Barua Waiting Your Turn: 2017 Report i Contents Executive summary / iii Findings / 1 Method /
More informationApril, Please send feedback/correspondence to:
Report on Adult Cardiac Surgery: Isolated Coronary Artery Bypass Graft (CABG) Surgery, Isolated Aortic Valve Replacement (AVR) Surgery and Combined CABG and AVR Surgery October 2011 - March 2016 April,
More informationThe Delivery of Radical Prostatectomy to Treat Men With Prostate Cancer
The Delivery of Radical Prostatectomy to Treat Men With Prostate Cancer Technical Notes Health System Performance Our Vision Better data. Better decisions. Healthier Canadians. Our Mandate To lead the
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Mortality Measures Set
More informationIncreasing health care costs and a political movement toward balancing the budget
A case study of hospital and centralization of coronary revascularization procedures Brenda R. Hemmelgarn, * William A. Ghali, * Hude Quan * Abstract Background: Despite nation-wide efforts to reduce health
More informationNQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)
Last Updated: Version 4.3 NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE Measure Information Form Collected For: CMS Outcome Measures (Claims Based) Measure Set: CMS Readmission Measures Set
More informationWaiting Your Turn. Wait Times for Health Care in Canada, 2018 Report. by Bacchus Barua and David Jacques. with Antonia Collyer
Waiting Your Turn Wait Times for Health Care in Canada, 2018 Report by Bacchus Barua and David Jacques with Antonia Collyer 2018 Fraser Institute Waiting Your Turn Wait Times for Health Care in Canada,
More informationREPORT ON ADULT CARDIAC SURGERY IN ONTARIO
REPORT ON ADULT CARDIAC SURGERY IN ONTARIO ISOLATED CORONARY ARTERY BYPASS GRAFT (CABG) SURGERY ISOLATED AORTIC VALVE REPLACEMENT (AVR) SURGERY COMBINED CABG AND AVR SURGERY OCTOBER 2008 SEPTEMBER 2011
More informationHospital Length of Stay and Readmission for Individuals Diagnosed With Schizophrenia: Are They Related?
April 17, 2008 Hospital Length of Stay and Readmission for Individuals Diagnosed With Schizophrenia: Are They Related? Summary Pan-Canadian data show relatively high rates of readmission and declining
More informationTechnical Appendix for Outcome Measures
Study Overview Technical Appendix for Outcome Measures This is a report on data used, and analyses done, by MPA Healthcare Solutions (MPA, formerly Michael Pine and Associates) for Consumers CHECKBOOK/Center
More informationImplementing Rapid Response Teams (RRT) National Call September 13, 2007
Implementing Rapid Response Teams (RRT) National Call September 13, 2007 Purpose By the end of this call, participants will have: Heard successes and learnings from Improvement Teams Updated information
More informationAppendix B Fracture incidence and costs by province
1 Appendix B Fracture incidence and costs by province Comprehensive, accurate fracture numbers and costs are very important data that could help with prioritization and allocation of health care resources.
More informationTechnical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005
Technical Notes for PHC4 s Report on CABG and Valve Surgery Calendar Year 2005 The Pennsylvania Health Care Cost Containment Council April 2007 Preface This document serves as a technical supplement to
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Bucholz EM, Butala NM, Ma S, Normand S-LT, Krumholz HM. Life
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 89) is a regional and national referral center for percutaneous coronary intervention (PCI). A total of
More informationSupplementary Online Content
Supplementary Online Content Dharmarajan K, Wang Y, Lin Z, et al. Association of changing hospital readmission rates with mortality rates after hospital discharge. JAMA. doi:10.1001/jama.2017.8444 etable
More informationAPPENDIX EXHIBITS. Appendix Exhibit A2: Patient Comorbidity Codes Used To Risk- Standardize Hospital Mortality and Readmission Rates page 10
Ross JS, Bernheim SM, Lin Z, Drye EE, Chen J, Normand ST, et al. Based on key measures, care quality for Medicare enrollees at safety-net and non-safety-net hospitals was almost equal. Health Aff (Millwood).
More informationICD-10 Reciprocal Billing File Technical Specifications Reference Guide for Ontario Hospitals
ICD-10 Reciprocal Billing File Technical Specifications Reference Guide for Ontario Hospitals Ministry of Health and Long-Term Care Version 3 January 2014 ICD Reciprocal Billing File Technical Specifications
More informationAlex versus Xience Registry Preliminary report
Interventional Cardiology Network Alex versus Xience Preliminary report Mariusz Gąsior 1,2, Marek Gierlotka 1, Lech Poloński 1,2 1 3rd Department of Cardiology, Medical University of Silesia Centre tor
More informationEconomic Burden of Musculoskeletal Diseases in Canada
Economic Burden of Musculoskeletal Diseases in Canada Presented by Sylvie Desjardins, Policy Research Unit, Public Health Agency of Canada October 23 rd, 2006 1 Fact Sheet MSK has the higher prevalence
More informationCritical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery
Critical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery University of Ottawa Heart Institute Jean Yves Dupuis, MD, FRCPC Cardiac Division of Anesthesiology Disclosure
More informationMacrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment
Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment Record Status This is a critical abstract of an economic evaluation that meets
More informationReport from the National Diabetes Surveillance System:
Report from the National Diabetes Surveillance System: Diabetes in Canada, 28 To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health. Public
More informationBlue Distinction Centers for Cardiac Care 2018 Provider Survey
Blue Distinction Centers for Cardiac Care 2018 Provider Survey Printed version of this document is for reference purposes only. Paper copies of the Provider Survey and Team Table will not be accepted.
More informationProvincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association
ARTHRITIS COMMUNITY RESEARCH & EVALUATION UNIT (ACREU) The Arthritis and Immune Disorder Research Centre Health Care Research Division University Health Network February, 2000 Provincial Projections of
More informationReport on Coronary Artery Bypass Surgery in Ontario, Fiscal Years 2005/06 and 2006/07
Evidence guiding health care Report on Coronary Artery Bypass Surgery in Ontario, Fiscal Years 2005/06 and 2006/07 In collaboration with the Cardiac Care Network of Ontario July 2008 Report on Coronary
More informationSupplementary Online Content
Supplementary Online Content Valle JA, Tamez H, Abbott JD, et al. Contemporary use and trends in unprotected left main coronary artery percutaneous coronary intervention in the United States: an analysis
More informationWhy is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager
Why is co-morbidity important for cancer patients? Michael Chapman Research Programme Manager Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient in addition
More informationChapter 4: Cardiovascular Disease in Patients With CKD
Chapter 4: Cardiovascular Disease in Patients With CKD Introduction Cardiovascular disease is an important comorbidity for patients with chronic kidney disease (CKD). CKD patients are at high-risk for
More information2011 Measures Maintenance Technical Report: Acute Myocardial Infarction, Heart Failure, and Pneumonia 30 Day Risk Standardized Readmission Measures
2011 Measures Maintenance Technical Report: Acute Myocardial Infarction, Heart Failure, and Pneumonia 30 Day Risk Standardized Readmission Measures Submitted By Yale New Haven Health Services Corporation
More informationAppendix 1: Supplementary tables [posted as supplied by author]
Appendix 1: Supplementary tables [posted as supplied by author] Table A. International Classification of Diseases, Ninth Revision, Clinical Modification Codes Used to Define Heart Failure, Acute Myocardial
More informationReport on Adult Percutaneous Coronary Interventions (PCI) in Ontario: October March 2016
Report on Adult Percutaneous Coronary Interventions (PCI) in Ontario: October 2011 - March 2016 April, 2018 Please send feedback/correspondence to: Garth Oakes Staff Scientist CorHealth Ontario Email:
More informationWeekend Admission and In- Hospital Mortality: Should Patients Avoid Hospitals on Weekends? Canadian Institute for Health Information (CIHI)
Weekend Admission and In- Hospital Mortality: Should Patients Avoid Hospitals on Weekends? Canadian Institute for Health Information (CIHI) Background Reduced availability of some health care services
More informationFEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery
EUROPEAN SOCIETY OF CARDIOLOGY CONGRESS 2010 FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery Nicholas L Mills, David A McAllister, Sarah Wild, John D MacLay,
More informationTHE NATIONAL QUALITY FORUM
THE NATIONAL QUALITY FORUM National Voluntary Consensus Standards for Patient Outcomes Table of Measures Submitted-Phase 1 As of March 5, 2010 Note: This information is for personal and noncommercial use
More informationRisk Score for Predicting In-Hospital/30-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery
Risk Score for Predicting In-Hospital/3-Day Mortality for Patients Undergoing Valve and Valve/ Coronary Artery Bypass Graft Surgery Edward L. Hannan, PhD, Michael Racz, PhD, Alfred T. Culliford, MD, Stephen
More informationAcute Coronary Syndrome
ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to
More informationAPPROACH WORKING REPORT
APPROACH WORKING REPORT Diagnostic Cardiac Catheterization and Revascularization Rates for Coronary Heart Disease in Alberta Regional Health Authorities from 1995 to 2002 (Version 1). May 6, 2005 ACKNOWLEDGEMENTS
More informationWest Nile virus and Other Mosquito borne Diseases National Surveillance Report English Edition
and Other Mosquito borne Diseases National Surveillance Report English Edition July to July 8, 17 (Week 7) West Nile Virus Canada Humans As of surveillance week 7, ending on July 8, 17, the Public Health
More informationInformation Management. A System We Can Count On. Chronic Conditions. in the Central East LHIN
Information Management A System We Can Count On Chronic Conditions in the Central East LHIN Health System Intelligence Project October 2007 Table of Contents About HSIP..................................ii
More informationSupplementary Online Content
Supplementary Online Content Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova N. Trends in infective endocarditis in California and New York State, 1998-2013. JAMA. doi:10.1001/jama.2017.4287
More informationA Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery
A Novel Score to Estimate the Risk of Pneumonia After Cardiac Surgery Arman Kilic, MD 1, Rika Ohkuma, MD 1, J. Trent Magruder, MD 1, Joshua C. Grimm, MD 1, Marc Sussman, MD 1, Eric B. Schneider, PhD 1,
More informationThe Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University
The Changing Epidemiology of Acute Coronary Syndromes: Implications for practice: Dr. Sonia Anand, McMaster University Expert Opinions CCS Vancouver, BC October 23, 2011 Overview of ACS Epidemiology: Global
More informationDIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN
DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and
More informationEACTS Adult Cardiac Database
EACTS Adult Cardiac Database Quality Improvement Programme List of changes to Version 2.0, 13 th Dec 2018, compared to version 1.0, 1 st May 2014. INTRODUCTORY NOTES This document s purpose is to list
More informationUnstable angina and NSTEMI
Issue date: March 2010 Unstable angina and NSTEMI The early management of unstable angina and non-st-segment-elevation myocardial infarction This guideline updates and replaces recommendations for the
More informationWhat do the guidelines say?
Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European
More informationIschemic Heart Disease Interventional Treatment
Ischemic Heart Disease Interventional Treatment Cardiac Catheterization Laboratory Procedures (N = 11,61) is a regional and national referral center for percutaneous coronary intervention (PCI). A total
More informationIndications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014
Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such
More informationSupplementary material
Supplementary material Validation procedures To validate the quality of the diagnostic information in the Beijing Hospital Discharge Information System (HDIS), 1069 patients with acute myocardial infarction
More informationOxyContin in the 90 days prior to it being discontinued.
Appendix 1 (as supplied by the authors): Supplementary data Provincial Drug Insurance program formulary listing status for OxyNeo by province Province Listing of OxyNeo BC Listed for patients covered by
More informationCHAPTER 4: Population-level interventions
CHAPTER 4: Population-level interventions Population-level interventions refer to policies and programs that are applied to entire populations to promote better health outcomes. In this chapter, we describe
More informationDIABETES MORTALITY IN NOVA SCOTIA FROM 1998 TO 2005: A DESCRIPTIVE ANALYSIS USING BOTH UNDERLYING AND MULTIPLE CAUSES OF DEATH
DIABETES MORTALITY IN NOVA SCOTIA FROM 1998 TO 2005: A DESCRIPTIVE ANALYSIS USING BOTH UNDERLYING AND MULTIPLE CAUSES OF DEATH Alison Zwaagstra Health Information Analyst Network for End of Life Studies
More informationChairs: John Lainchbury & Andrew Aitken. Elderly/Frailty
Frailty Elderly/Frailty Ralph Stewart Chairs: John Lainchbury & Andrew Aitken Elderly/Frailty Ralph Stewart Green Lane Cardiovascular Service and Cardiovascular Research Unit Auckland City Hospital 1 What
More informationRates and patterns of participation in cardiac rehabilitation in Victoria
Rates and patterns of participation in cardiac rehabilitation in Victoria Vijaya Sundararajan, MD, MPH, Stephen Begg, MS, Michael Ackland, MBBS, MPH, FAPHM, Ric Marshall, PhD Victorian Department of Human
More informationSurgical Consensus Standards Endorsement Maintenance NQF-Endorsed Surgical Maintenance Standards (Phase I) Table of Contents
Table of Contents #0113: Participation in a Systematic Database for Cardiac Surgery... 2 #0114: Post-operative Renal Failure... 2 #0115: Surgical Re-exploration... 3 #0116: Anti-Platelet Medication at
More informationSupplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.
SUPPLEMENTAL MATERIAL Supplemental Table 1. Standardized Serum Creatinine Measurements Supplemental Table 2. List of ICD 9 and ICD 10 Billing Codes Supplemental Table 3. Sensitivity Analyses with Additional
More informationColorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT
Colorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT JANUARY 2011 DECEMBER 2012 Acknowledgments The Canadian Partnership Against Cancer would like to gratefully
More informationInfluenza Vaccination Coverage in British Columbia Canadian Community Health Survey 2011 & 2012
Background The Canadian Community Health Survey (CCHS) is a cross-sectional survey that collects information related to the health status, health care utilization and health determinants of the Canadian
More informationNATIONAL QUALITY FORUM
TO: NQF Members and Public FR: NQF Staff RE: Pre-comment review of an addendum to National Voluntary Consensus Standards: Cardiovascular Endorsement Maintenance 2010: A Consensus Report DA: October 6,
More informationXi Li, Jing Li, Frederick A Masoudi, John A Spertus, Zhenqiu Lin, Harlan M Krumholz, Lixin Jiang for the China PEACE Collaborative Group
China PEACE risk estimation tool for inhospital death from acute myocardial infarction: an early risk classification tree for decisions about fibrinolytic therapy Xi Li, Jing Li, Frederick A Masoudi, John
More informationTOTAL HIP AND KNEE REPLACEMENTS. FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES
TOTAL HIP AND KNEE REPLACEMENTS FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES The Pennsylvania Health Care Cost Containment Council April 2005 Preface This document serves as
More informationManitoba EMR Data Extract Specifications
MANITOBA HEALTH, HEALTHY LIVING AND SENIORS Manitoba Data Specifications Version 2 Updated: September 11, 2015 1 Introduction The purpose of this document is to describe the data to be included in the
More informationParis, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators
Paris, August 28 th 2011 Is TAVI the definitive treatment in high risk patients? Impact Of Coronary Artery Disease In Elderly Patients Undergoing TAVI: Insight The Italian CoreValve Registry Gian Paolo
More informationWhat oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor
76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class
More informationPhysical Medicine & Rehabilitation. Physical Medicine and Rehabilitation Profile
Physical Medicine & Rehabilitation Updated March 2018 Click on any of the contents below to navigate to the slide. Please click the home icon located at the top right of each slide to return to the table
More informationCARDIOLOGY GRAND ROUNDS
CARDIOLOGY GRAND ROUNDS Presentation: Date: Location: Speaker: ACC 2015 PREVIEW Monday, March 9, 2015, 7:00 8:00 AM ANW Education Building, Watson Room Elevated Troponin in Patients Presenting to the Emergency
More informationCritical Care Medicine. Critical Care Medicine Profile
Updated March 2018 Click on any of the contents below to navigate to the slide. Please click the home icon located at the top right of each slide to return to the table of contents slide. TABLE OF CONTENTS
More informationTENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 4 Episodes
TENNCARE Bundled Payment Initiative: Description of Bundle Risk Adjustment for Wave 4 Episodes Attention deficit hyperactivity disorder (ADHD); Opposition defiance disorder (ODD); Coronary artery bypass
More informationGeneral Internal Medicine. General Internal Medicine Profile
Updated March 2018 1 Click on any of the contents below to navigate to the slide. Please click the home icon located at the top right of each slide to return to the table of contents slide. TABLE OF CONTENTS
More informationSupporting New Funding Approaches using CIHI s Classification Systems. Health Data Users Day May 27, 2013 Greg Zinck, Manager, Case Mix
Supporting New Funding Approaches using CIHI s Classification Systems. Health Data Users Day May 27, 2013 Greg Zinck, Manager, Case Mix 1 Outline CIHI Groupers and CIHI Data Case Mix, Cost, Case Costing,
More informationREPORT ON ADULT PERCUTANEOUS CORONARY INTERVENTIONS (PCI) IN ONTARIO OCTOBER SEPTEMBER 2011
REPORT ON ADULT PERCUTANEOUS CORONARY INTERVENTIONS (PCI) IN ONTARIO OCTOBER 2008 - SEPTEMBER 2011 April 2013 Please send feedback/correspondence to: Kori Kingsbury Chief Executive Officer Cardiac Care
More informationThey are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:
Assessment and immediate management of suspected acute coronary syndrome bring together everything NICE says on a topic in an interactive flowchart. are interactive and designed to be used online. They
More informationBeta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes
Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National
More informationSupplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.
Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical
More informationAPPENDIX F: CASE REPORT FORM
APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more
More informationDemand for Ocular Tissue in Canada - Final Report
Demand for Ocular Tissue in Canada - Final Report January 2010 Table of Contents Executive Summary... 3 Background... 4 Purpose... 4 Overview... 4 Limitations... 4 Waiting Lists for Cornea Transplants...
More informationTYPE II MI. KC ACDIS LOCAL CHAPTER March 8, 2016
TYPE II MI KC ACDIS LOCAL CHAPTER March 8, 2016 TYPE 2 MI DEFINITION: Acute coronary syndrome (ACS) encompasses a continuum of myocardial ischemia and infarction, which can make the diagnostic and coding
More informationConsensus Core Set: Cardiovascular Measures Version 1.0
Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized
More informationBackground- Methods-
ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE- Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data Jing Li, Xi Li, Qing
More informationPreoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery?
Preoperative Anemia versus Blood Transfusion: Which is the Culprit for Worse Outcomes in Cardiac Surgery? Damien J. LaPar MD, MSc, James M. Isbell MD, MSCI, Jeffrey B. Rich MD, Alan M. Speir MD, Mohammed
More informationDUKECATHR Dataset Dictionary
DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of
More informationRandomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial
Randomized comparison of single versus double mammary coronary artery bypass grafting: 5 year outcomes of the Arterial Revascularization Trial Embargoed until 10:45 a.m. CT, Monday, Nov. 14, 2016 David
More informationCatheter-based mitral valve repair MitraClip System
Percutaneous Mitral Valve Repair: Results of the EVEREST II Trial William A. Gray MD Director of Endovascular Services Associate Professor of Clinical Medicine Columbia University Medical Center The Cardiovascular
More informationAussi disponible en français sous le titre : Le Diabète au Canada : Rapport du Système national de surveillance du diabète, 2009
Report from the National Diabetes Surveillance System: Diabetes in Canada, 29 To promote and protect the health of Canadians through leadership, partnership, innovation and action in public health. Public
More informationWhy is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme
Why is co-morbidity important for cancer patients? Di Riley Associate Director Clinical Outcomes Programme Co-morbidity in cancer Definition:- Co-morbidity is a disease or illness affecting a cancer patient
More informationLAMA Products for the Treatment of COPD
FINAL REPORT LAMA Products for the Treatment of COPD Pharmacoepidemiology Unit: Censored Final Report Tara Gomes, Andrea Gershon, Matthew Stanbrook, Ximena Camacho, Diana Martins, Samantha Singh, Zhan
More informationMeasure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care
Measure #167 (NQF 0114): Coronary Artery Bypass Graft (CABG): Postoperative Renal Failure National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE
More informationMeasuring health care inequalities using the Census- DAD data linkage
Measuring health care inequalities using the Census- DAD data linkage Erin Pichora, Program Lead Canadian Population Health Initiative Canadian Institute for Health Information November 14, 2017 Epichora@cihi.ca
More informationClinical Outcome in Patients with Aortic Stenosis
Clinical Outcome in Patients with Aortic Stenosis Is the Prognosis Worse in Patients with Low-Gradient Severe Aortic Stenosis? Yoel Angel BSc, Shemy Carasso MD, Diab Mutlak MD, Jonathan Lessick MD Dsc,
More information$1.4 Million Allocated to Cardiac Rehabilitation Services!
$1.4 Million Allocated to Cardiac Rehabilitation Services! Cardiac Rehabilitation in New Brunswick- A Province on the Move! Background The incidence of cardiovascular disease (CVD) in New Brunswick (NB)
More information2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome
Measure #445 (NQF 0119): Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY
More informationPatient characteristics Intervention Comparison Length of followup
ISCHAEMIA TESTING CHAPTER TESTING FOR MYCOCARDIAL ISCHAEMIA VERSUS NOT TESTING FOR MYOCARDIAL ISCHAEMIA Ref ID: 4154 Reference Wienbergen H, Kai GA, Schiele R et al. Actual clinical practice exercise ing
More informationAchievements
Celebrating our Achievements 1999-2014 Executive summary www.canadianstrokenetwork.ca Celebrating our Achievements Canadian Stroke Network 1999-2014 Our mission was to reduce the impact of stroke on Canadians
More information3309 Risk-Standardized Survival Rate (RSSR) for In-Hospital Cardiac Arrest (American Heart Association)
Memo March 8, 2018 To: NQF Members and the Public From: NQF Staff Re: Commenting Draft Report: National Voluntary Consensus Standards for Cardiovascular Background This report reflects the review of measures
More informationSafety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD
Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell
More informationTechnical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham
Improvement Analytics Unit September 2018 Technical appendix: The impact of integrated care teams on hospital use in North East Hampshire and Farnham Therese Lloyd, Richard Brine, Rachel Pearson, Martin
More information